Biokinetics and dosimetry in patients administered with (111)ln-DOTA-Tyr(3)-octreotide: implications for internal radiotherapy with (90)Y-DOTATOC. - Cremonesi,M.; Ferrari,M.; Zoboli,S.; Chinol,M.; Stabin,M.G.; Orsi,F.; Maecke,H.R.; Jermann,E.; Robertson,C.; Fiorenza,M.; Tosi,G.; Paganelli,G. (Eur J Nucl Med, 1999)